pharma news today obesity drugs glp-1 september 2025 Swiss Re says could reduce US mortality by up to 6.4% With China approval, Lilly and
Description
The FDA-approved prescribing information for all GLP-1 medications includes specific titration schedules designed to minimize gastrointestinal side effects
M., Boutron, I., Hoffmann, T
In the realm of autoimmune diseases and chronic inflammation, GLP-1s hold particular promise
Clinical potential of treatment with semaglutide in type 2 diabetes patients
patients over 10 years
